PTC raises $108.8M in follow-on

PTC Therapeutics Inc. (NASDAQ:PTCT) added $108.8 million to its coffers with its second big follow-on of 2014, selling 3 million shares at $36.25 in a deal underwritten by Credit Suisse; Citigroup; Cowen; Deutsche Bank; RBC Capital Markets; Oppenheimer; Roth Capital Partners; and Wedbush. The company proposed the offering after market close Oct. 8, when its shares finished the day at $39.42.

PTC closed Friday at $34.59, down $2. In February, it raised $110 million through the sale of 4.5 million shares at $24.50. It raised $125.6 million by selling 8.4 million shares at $15 in its June 2013 IPO. ...